JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6026
AmeriServ Financial
ASRV
$75.6M
| $46.6K | ﹤0.01% |
14,605
-10,395
| -42% | -$32K |
2024 Q3
5 quarters
|
|
6027
CALL
On Holding
ONON
$10.1B
| $46.5K | ﹤0.01% |
+1,000
| New | +$43.1K |
2025 Q4
0 quarters
|
|
6028
Invesco WilderHill Clean Energy ETF
PBW
$338M
| $46.3K | ﹤0.01% |
1,516
-2,063
| -58% | -$65.7K |
2020 Q3
21 quarters
|
|
6029
Crexendo
CXDO
$197M
| $46K | ﹤0.01% |
7,103
-3,573
| -33% | -$23.4K |
2025 Q2
2 quarters
|
|
6030
Galectin Therapeutics
GALT
$379M
| $45.9K | ﹤0.01% |
11,043
-4,427
| -29% | -$23.3K |
2019 Q1
27 quarters
|
|
6031
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$346M
| $45.8K | ﹤0.01% |
1,086
+399
| +58% | +$16.5K |
2023 Q4
8 quarters
|
|
|
NREF
6032
NexPoint Real Estate Finance
NREF
$297M
| $45.8K | ﹤0.01% |
3,253
-284
| -8% | -$3.97K |
2021 Q1
19 quarters
|
|
6033
PUT
Celsius Holdings
CELH
$6.94B
| $45.7K | ﹤0.01% |
1,000
| – | – |
2024 Q1
7 quarters
|
|
|
INV
6034
Innventure Inc
INV
$41M
| $45.7K | ﹤0.01% |
+10,928
| New | +$45.9K |
2025 Q4
0 quarters
|
|
6035
Lucid Diagnostics
LUCD
$121M
| $45.2K | ﹤0.01% |
41,506
+5,408
| +15% | +$6.05K |
2023 Q3
9 quarters
|
|
|
UXAP
6036
FT Vest U.S. Equity Uncapped Accelerator ETF - April
UXAP
$13.1M
| $45.2K | ﹤0.01% |
1,161
+400
| +53% | +$15.4K |
2025 Q3
1 quarter
|
|
|
TUYA
6037
Tuya Inc
TUYA
$1.05B
| $45.1K | ﹤0.01% |
21,394
-1,863,206
| -99% | -$4.25M |
2022 Q3
13 quarters
|
|
6038
Journey Medical
DERM
$190M
| $45K | ﹤0.01% |
5,839
+900
| +18% | +$7.06K |
2025 Q2
2 quarters
|
|
6039
SoFi Select 500 ETF
SFY
$701M
| $44.9K | ﹤0.01% |
340
-3,360
| -91% | -$442K |
2025 Q3
1 quarter
|
|
6040
1-800-Flowers.com
FLWS
$164M
| $44.9K | ﹤0.01% |
11,418
-1,986
| -15% | -$7.8K |
2017 Q4
32 quarters
|
|
6041
Biote Corp
BTMD
$33.3M
| $44.7K | ﹤0.01% |
17,204
+428
| +3% | +$1.17K |
2023 Q2
10 quarters
|
|
6042
CALL
Affirm
AFRM
$23.8B
| $44.7K | ﹤0.01% |
600
-100
| -14% | -$7.2K |
2024 Q4
4 quarters
|
|
6043
Immuneering
IMRX
$261M
| $44.5K | ﹤0.01% |
6,765
+5,265
| +351% | +$33.8K |
2021 Q3
17 quarters
|
|
6044
CALL
Roper Technologies
ROP
$35.9B
| $44.5K | ﹤0.01% |
+100
| New | +$46.3K |
2025 Q4
0 quarters
|
|
6045
CALL
Fortive
FTV
$16.9B
| $44.2K | ﹤0.01% |
+800
| New | +$41.5K |
2025 Q4
0 quarters
|
|
6046
PUT
Oneok
OKE
$54.9B
| $44.1K | ﹤0.01% |
600
| – | – |
2023 Q4
8 quarters
|
|
6047
PUT
PACCAR
PCAR
$57.9B
| $43.8K | ﹤0.01% |
400
| – | – |
2025 Q3
1 quarter
|
|
6048
BuzzFeed
BZFD
$98.2M
| $43.7K | ﹤0.01% |
47,036
+34,665
| +280% | +$43.8K |
2025 Q3
1 quarter
|
|
6049
InnovAge Holding
INNV
$1.2B
| $43.5K | ﹤0.01% |
8,378
-7,615
| -48% | -$40K |
2021 Q1
19 quarters
|
|
|
DVLT
6050
Datavault AI
DVLT
$148M
| $43.4K | ﹤0.01% |
67,737
-214,925
| -76% | -$376K |
2025 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.